title: Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.
abstract: Carcinogenesis is a multi-step series of somatic genetic events. The complexity of this multi-hit process makes it difficult to determine each single event and the definitive outcome of such events. To investigate the genetic alterations in cancer-related genes, sensitive and reliable detection methods are of major importance for generating relevant results. Another critical issue is the quality of starting material which largely affects the outcome of the analysis. Microdissection of cells defined under the microscope ensures a selection of representative material for subsequent genetic analysis. Skin cancer provides an advantageous model for studying the development of cancer. Detectable lesions occur early during tumor progression, facilitating molecular analysis of the cell populations from both preneoplastic and neoplastic lesions. Alterations of the p53 tumor suppressor gene are very common in non-melanoma skin cancer, and dysregulation of p53 pathways appear to be an early event in the tumor development. A high frequency of epidermal p53 clones has been detected in chronically sun-exposed skin. The abundance of clones containing p53 mutated keratinocytes adjacent to basal cell (BCC) and squamous cell carcinoma (SCC) suggests a role in human skin carcinogenesis. Studies using p53 mutations as a clonality marker have suggested a direct link between actinic keratosis, SCC in situ and invasive SCC. Microdissection-based studies have also shown that different parts of individual BCC tumors can share a common p53 mutation yet differ with respect to additional alterations within the p53 gene, consistent with subclonal development within tumors. Here, we present examples of using well-defined cell populations, including single cells, from complex tissue in combination with molecular tools to reveal features involved in skin carcinogenesis.
authors.affiliation: Department of Pathology, University Hospital Uppsala, SE-751 85 Uppsala, Sweden.
authors.forename: Helena
authors.initials: H
authors.lastname: Bäckvall
authors.forename: Anna
authors.initials: A
authors.lastname: Asplund
authors.forename: Anna
authors.initials: A
authors.lastname: Gustafsson
authors.forename: Asa
authors.initials: A
authors.lastname: Sivertsson
authors.forename: Joakim
authors.initials: J
authors.lastname: Lundeberg
authors.forename: Fredrik
authors.initials: F
authors.lastname: Ponten
mesh_terms: D002280:Basal Cell Carcinoma / Q000235:genetics*; D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D018740:Genetic Heterogeneity; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000235:genetics; D012878:Skin Neoplasms / Q000235:genetics*; D014466:Ultraviolet Rays